We Are One Seven LLC purchased a new stake in Cerner Co. (NASDAQ:CERN) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 8,554 shares of the company’s stock, valued at approximately $576,000.
Other institutional investors also recently modified their holdings of the company. Geode Capital Management LLC raised its stake in shares of Cerner by 2.7% in the 4th quarter. Geode Capital Management LLC now owns 3,759,894 shares of the company’s stock valued at $252,916,000 after buying an additional 98,444 shares in the last quarter. Kalos Management Inc. raised its stake in shares of Cerner by 32.9% in the 3rd quarter. Kalos Management Inc. now owns 13,155 shares of the company’s stock valued at $938,000 after buying an additional 3,254 shares in the last quarter. Paloma Partners Management Co acquired a new stake in shares of Cerner during the 4th quarter worth about $1,229,000. Capital International Investors increased its position in shares of Cerner by 0.3% during the 3rd quarter. Capital International Investors now owns 4,851,296 shares of the company’s stock worth $345,994,000 after purchasing an additional 12,178 shares in the last quarter. Finally, Fieldpoint Private Securities LLC acquired a new stake in shares of Cerner during the 3rd quarter worth about $559,000. 78.54% of the stock is owned by hedge funds and other institutional investors.
A number of equities research analysts recently issued reports on the stock. SunTrust Banks dropped their target price on shares of Cerner from $68.00 to $2.82 and set a “hold” rating for the company in a research report on Wednesday, February 7th. Cantor Fitzgerald dropped their target price on shares of Cerner from $83.00 to $80.00 and set an “overweight” rating for the company in a research report on Wednesday, February 7th. Argus cut shares of Cerner from a “buy” rating to a “hold” rating and increased their target price for the stock from $54.49 to $64.65 in a research report on Tuesday, March 13th. BidaskClub cut shares of Cerner from a “sell” rating to a “strong sell” rating in a research report on Thursday, March 15th. Finally, Evercore ISI assumed coverage on shares of Cerner in a research report on Thursday, January 18th. They set an “in-line” rating and a $77.00 target price for the company. One equities research analyst has rated the stock with a sell rating, twelve have given a hold rating and nine have assigned a buy rating to the company’s stock. Cerner has an average rating of “Hold” and a consensus price target of $67.50.
Shares of Cerner stock opened at $59.86 on Thursday. Cerner Co. has a fifty-two week low of $56.17 and a fifty-two week high of $73.86. The company has a current ratio of 3.01, a quick ratio of 2.99 and a debt-to-equity ratio of 0.11. The company has a market cap of $19,769.58, a PE ratio of 23.29, a price-to-earnings-growth ratio of 1.73 and a beta of 0.93.
Cerner (NASDAQ:CERN) last issued its quarterly earnings data on Tuesday, February 6th. The company reported $0.58 EPS for the quarter, missing analysts’ consensus estimates of $0.61 by ($0.03). Cerner had a return on equity of 16.82% and a net margin of 16.86%. The company had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.33 billion. During the same period in the prior year, the company earned $0.61 EPS. The firm’s revenue was up 4.5% compared to the same quarter last year. equities analysts forecast that Cerner Co. will post 2.42 earnings per share for the current year.
In other news, Vice Chairman Clifford W. Illig sold 307,700 shares of the firm’s stock in a transaction dated Thursday, March 8th. The shares were sold at an average price of $64.52, for a total value of $19,852,804.00. Following the transaction, the insider now owns 1,229,719 shares of the company’s stock, valued at approximately $79,341,469.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William D. Zollars sold 4,100 shares of the firm’s stock in a transaction dated Thursday, February 8th. The shares were sold at an average price of $62.16, for a total transaction of $254,856.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 541,800 shares of company stock worth $34,353,860. Insiders own 13.11% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “8,554 Shares in Cerner Co. (CERN) Purchased by We Are One Seven LLC” was originally reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this report on another site, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this report can be viewed at https://ledgergazette.com/2018/03/22/8554-shares-in-cerner-co-cern-purchased-by-we-are-one-seven-llc.html.
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.